Related Experiment Video
Updated: Dec 14, 2025

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.6K
Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
1Department of Urology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Translational Andrology and Urology
|July 18, 2020
Abstract
No abstract available in PubMed .

